Skip to main content

Schedule H1 Records for Indian Clinics: Supply, Registers and 2026 Updates

For a supply covered by Rule 65(3)(h) of India’s Drugs Rules, Schedule H1 recording happens at the time of supply in a separate register. The provision names the prescriber and address, patient, drug and quantity supplied, with records maintained for three years and available for inspection. First establish the clinic’s dispensing and licensing context; prescribing, dispensing and maintaining a patient record are different activities.

By Bractis · Updated · 15 min read

Indian clinic owners, prescribing doctors and appropriately authorized dispensary personnel clarifying Schedule H1 records and catalogue updates.

Does writing a prescription create a Schedule H1 supply entry?

A doctor may prescribe a medicine that the patient purchases from an independent pharmacy. In another setting, an authorized dispensary associated with the clinic may supply it. Those arrangements involve different records and responsibilities. A prescription draft is evidence of an intended order; it is not evidence that a quantity was handed to the patient.

Before configuring a register, document who supplies medicines, under what applicable licence or other lawful basis, and who is responsible for the records. Do not assume that owning an EMR, employing a doctor or printing a receipt establishes permission to operate a retail pharmacy. Confirm the actual arrangement with the relevant licensing authority or an appropriately qualified adviser.

This distinction also prevents a common software error: generating dispensing entries from every prescription, including unfilled and cancelled orders. Connect the register to a verified supply event within the applicable process. If the clinic only prescribes, its clinical record still needs to identify what the doctor ordered, but an external pharmacy’s supply should not be fabricated.

What does Rule 65(3)(h) actually specify?

The CDSCO compilation of the Drugs Rules contains the separate-register provision for Schedule H1 supply. Its listed particulars are the prescriber’s name and address, the patient’s name, the drug’s name and the quantity supplied. Recording is at the time of supply; the records are to be maintained for three years and remain open for inspection.

The table separates those particulars from additional operational fields proposed here. A timestamp, internal supply identifier or batch link can help reconstruct an event, but should not be misrepresented as wording taken from that sub-rule. Other applicable provisions and licence conditions may add requirements.

On a narrow screen, scroll the table horizontally to read all columns.

Published H1 register particulars and useful event links
ElementBasisPractical recording decision
Prescriber name and addressNamed in Rule 65(3)(h)Retain the relevant details with the supply record
Patient nameNamed in Rule 65(3)(h)Link to the correct patient; a shared family phone is not sufficient identity
Drug name and quantity suppliedNamed in Rule 65(3)(h)Record actual supply with an unambiguous quantity unit
Time, supply identifier and prescription linkAdditional workflow proposal hereConnect the event to the order without treating ordered quantity as supplied quantity
Batch, operator and amendment historyAdditional traceability proposal hereSupport investigation and transparent corrections within the clinic’s applicable obligations

Source: CDSCO: Drugs Rules, 1945, consolidated through July 2024

A 2026 example: final notification does not mean immediate commencement

Schedule H1 should not be treated as a permanent list copied once into a spreadsheet. Nor is it simply a synonym for all antibiotics. A classification decision needs the current applicable schedule, relevant amendments and their commencement provisions. The official Gazette register contains both drafts and final notifications; their legal stages are different.

Pregabalin illustrates the distinction. The January 2026 G.S.R. 54(E) document was a draft. The later final G.S.R. 377(E), dated 13 May 2026 and appearing in the Gazette dated 20 May 2026, provides for adding pregabalin to Schedule H1 after 180 days from publication. As of this guide’s check on 28 October 2026, that period has not elapsed. This is a future-commencement amendment at that checkpoint, not evidence that the addition is already operative.

That observation concerns this amendment’s commencement only; it does not imply unrestricted sale or resolve other requirements for the medicine. Before applying a rule to an actual transaction, verify the current official text and any later change. Keep the document, publication date, commencement rule and person who approved the catalogue update together.

Source: Gazette of India: G.S.R. 377(E), Drugs (Second Amendment) Rules, 2026

Source: CDSCO: Gazette notifications

Keep a status record for each amendment, not just a drug-list checkbox

The CDSCO listing checked for this pass also labels G.S.R. 745(E), dated 19 August 2026, as a draft concerning four additional H1 drugs. That listing is a discovery aid, not the full operative text. It does not establish that a later final notification is absent. Before changing a live classification, retrieve the applicable instrument and resolve its status and commencement with the person responsible for the clinic’s legal arrangement.

A catalogue can have a pending change without treating it as effective for every earlier transaction. Give pending changes an owner and an explicit review trigger. If the software cannot represent future commencement, document the controlled manual update needed at the appropriate time; do not change historic records in advance merely because a final notification has been uploaded.

This status table is deliberately limited to the documents cited here. It is not a complete current H1 list. It demonstrates what staff should preserve when a news headline, a supplier message and a Gazette document appear to disagree: the exact instrument, its stage and the unresolved decision.

On a narrow screen, scroll the table horizontally to read all columns.

How to record the cited 2026 instruments at the 28 October checkpoint
InstrumentEvidence inspectedStatus supported by that evidenceCatalogue decision
G.S.R. 54(E), 21 January 2026Its draft history is described in the final G.S.R. 377(E)Earlier proposal; use the final instrument for the resulting amendmentDo not treat the January proposal date as commencement
G.S.R. 377(E), 13 May 2026Final Gazette text dated 20 May; 180-day commencement clauseFinal amendment with the stated period not elapsed on 28 OctoberRetain publication and commencement evidence; recheck before applying to a transaction
G.S.R. 745(E), 19 August 2026CDSCO notification-index entryListed as a draft; full text and any later final instrument need checkingDo not activate proposed additions from the listing alone

Source: Gazette of India: G.S.R. 377(E), Drugs (Second Amendment) Rules, 2026

Source: CDSCO: Gazette notifications

Record partial supplies as separate real events

Consider a fictional prescription for 12 units of an H1-classified item. The authorized dispensary supplies 8 units on one occasion and 4 later, where the later supply is permitted under the applicable prescription and rules. The operational history contains two supply events totalling 12 units. Copying “12” from the prescription into each event would falsely record 24.

Record the quantity and unit at each actual handover, with a link to the prescription and earlier event. Preserve the difference between a planned balance and a completed later supply. The pending balance is not a reason to assume that the patient returned or that a second supply was legally permitted.

A prescription cancelled before any medicine leaves the dispensary should not appear as completed supply. A return after supply is different again: retain the original event and record the return and disposition separately. Do not erase the first entry to make the inventory and register look simpler.

Worked ledger: distinguish supply, backfill, return and correction

Expand the 12-unit example into a fictional evidence ledger. Assume both supplies have first been established as permitted under the applicable prescription and lawful supply arrangement. The item is an invented H1-classified tablet for recordkeeping practice; the quantities are not a recommended course. Every true supply retains the required particulars. The references and other event links below are additional operational suggestions.

The two actual supplies total 8 + 4 = 12 tablets. Importing the first paper entry after an outage is a representation of the same eight-tablet event, not a third handover. If that import is counted again, the apparent supplied total becomes 20. If two tablets are later returned, gross supplied remains 12 and separately recorded returns are 2. The net outward movement is 10, which says nothing about doses taken or the patient’s current remaining tablets.

A return should not automatically become available stock. Keep the return’s identity, condition and disposition within the authorized process, including any quarantine decision. Similarly, a correction to a quantity description is not another stock movement. Separating these events allows clinical, supply and inventory reviewers to answer their own questions without rewriting the original supply to make one total convenient.

On a narrow screen, scroll the table horizontally to read all columns.

Fictional record links: only H-201 and H-202 are separate supply events
Reference and eventQuantity representedSupporting evidenceHow to count and preserve it
H-201 — first actual supply8 tablets suppliedContemporaneous paper entry P-17 and relevant prescriptionCount 8 once; retain particulars and original source
H-202 — later permitted supply4 tablets suppliedNew handover evidence linked to the prescription and H-201Count 4 once; remaining planned quantity alone would not establish supply
B-201 — digital backfill of P-17Same 8 tablets as H-201Source reference P-17; recorded entry and import timesCount no additional supply; link the two representations
R-201 — return linked to H-2012 tablets returnedSeparate receipt and disposition recordShow returns separately; do not replace H-201 with 6
C-201 — quantity-unit clarification8 unspecified units clarified as 8 tabletsOriginal entry plus verified source and reason for amendmentRetain old and corrected wording; no new physical movement

Make responsibilities workable at a small clinic counter

Specify who verifies the applicable prescription and medicine classification, who records the supply and who resolves a missing detail. The same person may perform more than one authorized task in a small setup, but a shared login makes it harder to establish who actually acted. Record individual responsibility wherever the workflow permits.

At handover, compare the selected medicine and quantity with the actual item. A catalogue flag attached to the wrong formulation does not cure a product-identification error. If the catalogue status is disputed, route it to the named reviewer instead of letting reception staff override a warning merely to finish the bill.

A paper fallback also needs a reconciliation rule. Use a dated, attributable entry under the clinic’s approved process, then link the later digital entry to that source. Preserve the original supply time and the later entry time separately. A network outage must not result in two apparently independent supplies when the system returns.

Close a downtime entry with evidence of reconciliation

A clinic should agree its fallback recording arrangement before an outage and verify that arrangement against the relevant authority’s expectations. Later data entry cannot retroactively make a missing contemporaneous record complete. Staff should preserve the actual source and escalate omissions transparently rather than invent a supply time or backdate an entry to appear compliant.

For fictional H-201, the supply was recorded on paper at 10:05 and transcribed after service returned at 12:20. Keep both times with their meanings. If two staff members import P-17, the source reference should reveal that they are reconciling one event. A match on patient name and drug alone is insufficient: the same person could have another valid supply, and two patients can share a name.

The completed handover below records a hypothetical problem found during reconciliation. It is not a prescribed statutory form. The second person checks the paper source, the visible digital particulars and the export. Mark the issue unresolved if source evidence cannot establish the unit; a supervisor’s click is not evidence that eight unspecified units were tablets.

Can an electronic register replace the clinic’s existing format?

Do not infer format acceptance from a vendor’s “H1 compliant” label. Establish the relevant authority’s expectations for the clinic’s specific arrangement, including availability for inspection, the particulars recorded, retention, corrections and the ability to produce usable records. The cited sub-rule alone is not a product certification.

Try an inspection-style retrieval with fictional data: choose a date range, identify the relevant supply, see the particulars and follow the link to its source. Repeat after an amendment and from an export. A screen that only shows current values may omit the evidence needed to explain a corrected quantity.

For retention planning, keep this supply-register requirement separate from the retention policy for clinical notes, prescriptions, inventory records and backups. A three-year provision for one record category does not authorize automatic deletion of all OPD records at three years.

Review exceptions rather than counting completed rows

A full register is not necessarily an accurate register. Sample an actual supply against its source, inspect entries with missing prescriber details and compare partial supplies with the quantities recorded. Include cancelled prescriptions, returned stock and later corrections in the review so the normal path does not hide exception errors.

For a fictional review of 20 supply events, suppose 18 can be reconstructed and two have unclear quantity units. Report two unresolved events out of 20, identify their owners and repair them transparently from evidence. Do not report “100% compliant” just because all 20 rows contain some text.

Treat a rule update as a controlled change with an effective date. Brief the responsible staff, check catalogue flags and preserve what was applied to earlier events. Rewriting historical classifications without explanation can obscure whether the clinic acted under the rule in force at the time.

Test the export with the questions an unresolved event creates

Choose H-201 in a fictional date-range export. Can a reader identify the actual medicine and quantity, the required prescriber and patient particulars, the source record, and the explanation for C-201? Open the export away from the live screen. A link that only works for the original operator may be inadequate for the clinic’s inspection or continuity process. Confirm the actual accepted access and format requirements rather than assuming that a PDF or spreadsheet is sufficient.

Next inspect totals. The export should distinguish two supply events from a backfill, a return and a correction. Check whether filtering by entry time accidentally omits a supply recorded on paper earlier, or whether selecting the supply date hides a subsequent amendment. Decide how both views will be explained. The additional time fields help this reconciliation; they are not a substitute for the particulars named in the cited provision.

Keep a compact exception list: event reference, missing evidence, responsible person, next action and closure evidence. Avoid copying an entire register into email or a messaging group merely to resolve one unit mismatch. Use the clinic’s controlled access route for patient-linked records. A vendor demonstration should use fictional particulars and should show both successful retrieval and an intentionally unresolved entry.

One prescription, two supplies, one traceable history

A fictional authorized dispensary supplies 8 units and later 4 units against a 12-unit prescription, after verifying that the later supply is permitted. Each event records its own actual quantity and source link. During review, staff can distinguish the first supply, the pending balance and the completed second supply. The prescription is not used as a shortcut to manufacture either event.

Schedule H1 Supply Workflow Record

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Applicable activity
Confirm who prescribes, who supplies and the applicable licensing or other lawful arrangement.
Current classification
Record the official source and commencement status used for catalogue decisions.
Supply evidence
Reconstruct a partial supply, correction and downtime entry without double counting.
Inspection readiness
Verify particulars, accepted format, retrieval and the retention category with the responsible authority or adviser.

Questions doctors ask

Does entering a paper H1 record into software create another supply?

No. A transcription of the same event should link to its original source and retain supply time and later entry time separately. Count the actual handover once. Verify the clinic’s fallback and electronic-record arrangement against applicable requirements.

Should returned tablets be subtracted from the original H1 supply entry?

Preserve the original supply and record the return and disposition separately. In the fictional example, 12 supplied and 2 returned remain distinct facts; net outward movement of 10 does not show what the patient consumed or what stock may be reused.

Is Schedule H1 just a list of antibiotics?

No. Do not classify a medicine solely by calling it an antibiotic or another broad category. Check the applicable schedule and amendments, including commencement dates.

What particulars does Rule 65(3)(h) name for an H1 register?

It names the prescriber and address, patient, drug and quantity supplied. The entry is made at supply, with the records maintained for three years and available for inspection, subject to the provision’s applicable context.

Is the 2026 pregabalin addition already operative on 28 October 2026?

The cited final G.S.R. 377(E) specifies commencement after 180 days from Gazette publication in May 2026. That period has not elapsed at the guide’s 28 October checkpoint. Recheck the official position for an actual transaction; this does not establish that other restrictions are absent.

Can an EMR automatically establish Schedule H1 compliance?

No. Applicable authority, actual supply records, staff responsibilities, current classification, format acceptance and inspection access must be established. A software label cannot settle those questions.

Does the H1 three-year provision apply to every clinic record?

No. It concerns the cited supply records. Clinical notes, other dispensing records and related material need a retention schedule based on their own applicable requirements and circumstances.

Sources and scope

Updated on . Cited rule text, the pregabalin notification and the CDSCO Gazette listing checked on 28 October 2026. This guide distinguishes published provisions from original recording examples; it is not a complete legal search or a determination of a particular clinic’s licence, exemption or permitted dispensing activity. No independent clinical or legal review is claimed.

  • CDSCO: Drugs Rules, 1945, consolidated through July 2024

    Rule 65(3)(h), PDF page 44, checked 28 October 2026. The compilation is a base text, not a substitute for later amendments or applicable licence conditions. The fictional event ledger and correction procedure are original operational proposals.

  • Gazette of India: G.S.R. 377(E), Drugs (Second Amendment) Rules, 2026

    Final two-page notification checked 28 October 2026, including its account of the earlier draft, Gazette date and 180-day commencement provision. The checkpoint statement concerns this instrument, not every restriction or later transaction.

  • CDSCO: Gazette notifications

    Official discovery listing checked 28 October 2026; G.S.R. 745(E) appears as a draft. That index entry is not a review of its full text or proof that no later final instrument exists. Draft, final and commencement stages remain distinct.

Try the workflow
with Bractis.

Bring a fictional partial-supply example and the format confirmed for your dispensing arrangement to discuss register particulars, event history and retrieval in the available workflow.

Request a clinic demo